Rigel Pharmaceuticals, Inc. (RIGL)

NASDAQ: RIGL · IEX Real-Time Price · USD

8.42

+0.01 (0.12%)

At close: Jul 2, 2024, 4:00 PM

8.18

-0.24 (-2.85%)

After-hours: Jul 2, 2024, 6:28 PM EDT

Rigel Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 1997
Net Income	-25.09	-58.57	-17.91	-29.74	-66.89	Upgrade
Depreciation & Amortization	1.24	1	1.16	0.71	0.68	Upgrade
Share-Based Compensation	8.81	12.39	9.49	7.3	9.12	Upgrade
Other Operating Activities	9.3	-28.57	13.14	-30.44	15.59	Upgrade
Operating Cash Flow	-5.74	-73.76	5.88	-52.19	-41.51	Upgrade
Capital Expenditures	0.26	0.44	-0.63	-1.26	-1.46	Upgrade
Change in Investments	10.44	72.33	-79.41	48.73	-22.2	Upgrade
Other Investing Activities	-15	-	-	-	-	Upgrade
Investing Cash Flow	-4.3	72.78	-80.04	47.47	-23.66	Upgrade
Share Issuance / Repurchase	1.05	2.12	4.78	2.6	1.58	Upgrade
Debt Issued / Paid	19.95	19.54	0	9.98	9.79	Upgrade
Other Financing Activities	-2.63	-15.12	57.9	-	-	Upgrade
Financing Cash Flow	18.37	6.55	62.68	12.57	11.37	Upgrade
Net Cash Flow	8.33	5.57	-11.48	7.85	-53.8	Upgrade
Free Cash Flow	-5.48	-73.32	5.25	-53.45	-42.97	Upgrade
Free Cash Flow Margin	-4.69%	-60.97%	3.52%	-49.21%	-72.47%	Upgrade
Free Cash Flow Per Share	-0.32	-4.25	0.31	-3.17	-2.57	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).